Hyperparathyroidism - cinacalcet
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy
Summary
Cinacalcet is not generally recommended for treating people on dialysis who have hyperparathyroidism because of their kidney disease. However, it is recommended for people on dialysis who: have very high levels of parathyroid hormone in their blood that can't be lowered by other treatme ...
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in December 2009
About this guidance
Technology appraisals TA117
Issued: January 2007
How this guidance was produced
